Earnings Feed
Start Free
Home/Insiders/Leonard Frank X
LF
SEC Insider//CIK 0001822879

Leonard Frank X

CIK 00018228791 companyWAYNE, PA
SEC Profile

Transactions

50

Companies

1

Filings

12

CIK

0001822879

Recent Transactions

50 trades
  • Tax Payment
    NovoCure Ltd$NVCR

    Ordinary Shares

    2025-11-01$12.81/sh−966→ 347,745 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2025-06-30$15.13/sh+833→ 348,711 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2025-06-04+179,426→ 347,878 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2025-06-02$17.99/sh−6,600→ 170,331 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2025-06-02$19.01/sh−1,879→ 168,452 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2025-06-02$17.22/sh−21,717→ 176,931 total
  • Award
    NovoCure Ltd$NVCR

    Stock Options (Right to buy)

    2025-03-04$18.19/sh+81,499→ 81,499 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2025-03-04$18.19/sh+54,975→ 198,648 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2025-03-03$18.54/sh−2,527→ 143,673 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2025-02-28$18.28/sh−2,770→ 146,200 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2025-02-28$18.28/sh−2,770→ 146,200 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2025-02-27$19.92/sh−10,277→ 150,959 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2025-02-27$20.55/sh−1,989→ 148,970 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2025-02-27$19.92/sh−10,277→ 150,959 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2025-02-27$20.55/sh−1,989→ 148,970 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2024-11-01$15.94/sh−598→ 161,236 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2024-06-28$12.24/sh+1,736→ 161,834 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2024-03-04$16.01/sh−840→ 160,098 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2024-03-01$16.03/sh−1,679→ 160,938 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2024-02-28$16.14/sh−2,078→ 162,617 total
  • Award
    NovoCure Ltd$NVCR

    Stock Options (Right to buy)

    2024-02-27$16.30/sh+156,348→ 156,348 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2024-02-27$16.30/sh+102,249→ 164,695 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-03-07$75.00/sh−6,003→ 56,599 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-03-07$75.59/sh−2,315→ 54,284 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-03-03$77.64/sh−2,059→ 67,893 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-03-03+11,808→ 69,952 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-03-03$76.16/sh−4,403→ 63,490 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-03-03$76.16/sh−888→ 62,602 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-03-02$75.28/sh−844→ 58,144 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-03-02$76.05/sh−308→ 58,988 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-03-02$75.32/sh−3,799→ 59,296 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-03-01$76.36/sh−1,684→ 63,095 total
  • Award
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-02-28+18,621→ 64,779 total
  • Award
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2023-02-28$76.97/sh+30,971→ 30,971 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-01-05$108.00/sh−5,517→ 46,158 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-01-05$7.15/sh+5,517→ 51,675 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-01-05$11.46/sh+7,500→ 53,658 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-01-05$108.00/sh−7,826→ 46,158 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2023-01-05−7,183→ 17,662 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-01-05$108.00/sh−417→ 47,694 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-01-05$119.01/sh−2,345→ 48,111 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2023-01-05−7,183→ 10,479 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-01-05$120.00/sh−7,183→ 46,158 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-01-05$21.15/sh+7,183→ 53,341 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-01-05$108.00/sh−7,500→ 46,158 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-01-05$14.37/sh+7,826→ 53,984 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-01-05$117.00/sh−1,010→ 46,158 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2023-01-05$115.03/sh−526→ 47,168 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2023-01-05−7,500→ 0 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2023-01-05−5,517→ 0 total

Companies

1

Recent Filings

12

Address

C/O NOVOCURE INC. 1550 LIBERTY RIDGE DRIVE, SUITE 115

WAYNE, PA, 19087

View on SEC.gov